创胜集团医药-B
港股通 官网
( 06628.hk)
市盈率-2.27市净率0.75股息率0%上市时间2021-09-29股价1.13港币涨跌幅-1.74%成交金额8.15万港币换手率0.02%市值5.15亿港币H股市值5.15亿港币总股本4.55亿H股本4.55亿每手股数500上市至今年化投资收益率-39.99%
所属三级行业生物技术 (恒生) 市盈率122.29市净率4.46股息率0.37%恒生:医疗保健业药品及生物科技生物技术
备注 (1): 双击编辑备注
发表讨论

创胜集团医药-B(06628) - 历史董事名单

# 姓名职衔职位委任日期辞任日期
1陳瑋Independent Non Executive Director2023-08-23--
2SRINIVASAN KumarIndependent Non Executive Director2022-12-19--
3翁曉路Executive Director2022-03-21--
4唐稼松Independent Non Executive Director - A/F2021-09-14--
5張志華Independent Non Executive Director2021-09-14--
6包駿Independent Non Executive Director2021-09-142023-08-23
7石明Executive Director2021-03-312022-07-20
8朱達Executive Director2021-03-312022-06-26
9趙奕寧Non Executive DirectorChairman2018-12-01--
10錢雪明Executive DirectorCEO2012-10-18--